EmmanuelMichaelMahlisMD

Hematology/Oncology, Allergy & Immunology, Rheumatology

Chief Medical Officer

Dr. Mahlis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
300 Barr Harbor Dr
Five Tower Bridge, Suite 800
West Conshohocken, PA 19428
Phone+1 267-364-3616

Hackensack University Medical Center (Mountainside)Residency, Internal Medicine, 1989 - 1992
St. George's University School of MedicineClass of 1989

PubMed

21 citations
Treatment costs of cystoid macular edema among patients following cataract surgery.
Jordana K. Schmier, David W. Covert, Carolyn K Hulme-Lowe, Anmol Mullins, Emmanuel M Mahlis
Clinical Ophthalmology. 2016-03-16
103 citations
Who is using chronic acid suppression therapy and why
Brian C. Jacobson, Timothy G. Ferris, Tara L. Shea, Emmanuel M. Mahlis, Thomas H. Lee
The American Journal of Gastroenterology. 2003-01-01

Journal Articles

Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Outcomes in Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) in Patients With or Without Recent Intr...
Messina, John; Hussain, Iftikhar; Carothers, Jennifer; Mahlis, Emmanuel; Mahmoud, Ramy, Journal of Allergy and Clinical Immunology
EDS-FLU Improves Quality of Life and Health Status: Pooled Analysis of Phase 3 Trials Navigate I and II
Velez, Fulton; Mahlis, Emmanuel; Messina, John; Colman, Sam; Anastassopoulos, Kate; Mahmoud, Ramy, Journal of Allergy and Clinical Immunology
Economic Impact Associated with a Reduction in Surgical Eligibility among Adult Patients with Chronic Rhinosinusitis - A Population Cost Offset Model
Smith, Nate; Velez, Fulton; Mahlis, Emmanuel; Medicis, Joseph; Messina, John; Beckerman, Rachel; Gricar, Joseph; Mahmoud, Ramy, Journal of Allergy and Clinical Immunology
Potential for population-level healthcare quality improvement with a new treatment modality for chronic rhinosinusitis
Velez, F.; Mahlis, Emmanuel; Messina, John; Mahmoud, Ramy, Annals of Allergy, Asthma & Immunology
A Rapid Reconstitution Method for CroFab® Polyvalent Immune Fab (ovine)
Gerring, David; Branton, Richard; Prime, Terry; King, Thomas; Mahlis, Emmanuel, Toxicon
Impact of a novel rapid reconstitution method on protein content for CroFab polyvalent immune fab, ovine
King, Thomas; Gerring, David; Branton, Richard; Mahlis, Emmanuel, Clinical Toxicology
Join now to see all

Abstracts/Posters

Economic Impact Associated with a Reduction in Surgical Eligibility among Newly Diagnosed Patients with Chronic Rhinosinusitis - A Managed Care Cost Offset Model
Fulton Velez, Emmanuel Mahlis, Joseph Medicis, John Messina, Rachel Beckerman, Joseph Gricar, Nathaniel Smith, Ramy Mahmoud, AMCP Nexus 2017

Vice President, Medical Affairs, Celgene Corp.
Vice President, Global Medical Affairs, BTG International
Senior Medical Positions, Merck & Co., Inc.
Head, US Medical Affairs, Alcon / Novartis
Vice President, Global Medical Affairs, OptiNose
Team Leader, Inflammation and Immunology, Dermatology -- US Medical Affairs, Pfizer
Senior Vice President, Global Medical Affairs, DBV Technologies